Original Article

Outcome of Systemic-to-Pulmonary Shunts in Cyanotic Congenital Heart Disease- A 9-year Experience

Abstract

The aim of this study is to evaluate early and late results of surgery in children with congenital heart disease and decreased pulmonary blood flow, who underwent a palliative systemic-to-pulmonary shunt. During the past 9 years, 157 systemic-to-pulmonary artery shunts were performed in 130 patients (69 males, 61 females) with ages from 1 day to 31 years old. They had been evaluated for their clinical effectiveness, the need for a repeat operation and the mortality and morbidity. There were 101 (77.7%) modified Blalock-Tausig (BT) shunts, 19 (14.6%) modified Waterston shunts, 8 (6.2%) Central shunts, 1 Waterston shunt, and 1 Glenn shunt created throughout the study. Tetralogy of Fallot comprised the majority of cases (113; 86.9%) while the remaining 17 (13.1%) included transposition of the great arteries with pulmonary stenosis, tricuspid atresia, pulmonary atresia, atrioventricular septal defect (canal) with pulmonary stenosis, and univentricular heart complex. Early mortality was 12.3% (16 patients). Second shunts were created in 25 (19.2%) patients. Forty patients (30.8%) have undergone subsequent intracardiac repair 37.7 ± 17.8 months after original shunt procedure. There were four (3%) late deaths. Follow-up was achieved in 105 of 114 early survivors for a pe-riod of 3 to 117 months (mean 31.7 ± 19.4 months). Modified BT shunt was performed most frequently in our service; it was associated with less closure and mortality than other types of shunt and had excellent clinical palliation and patency rates.

de Leval MR, McKay R, Jones M, Stark J, Macartney FJ. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemicpulmonary artery shunts. J Thorac Cardiovasc Surg 1981; 81(1): 112-9.

McKay R, de Leval MR, Rees P, Taylor JF, Macartney FJ, Stark J. Postoperative angiographic assessment of modified Blalock-Taussig shunts using expanded polytetrafluoroethylene (Gore-Tex). Ann Thorac Surg 1980; 30(2): 137-45.

Miyamoto K, Zavanella C, Lewin AN, Subramanian S. Aorta-pulmonary artery shunts with expanded polytetrafluoroethylene (PTFE) tube. Ann Thorac Surg 1979; 27(5): 413-7.

Bove EL, Sondheimer HM, Kavey RE, Byrum CJ, Blackman MS, Parker FB Jr. Subclavian-pulmonary artery shunts with polytetrafluorethylene interposition grafts. Ann Thorac Surg 1984; 37(1): 88-91.

Somerville J, Barbosa R, Ross D, Olsen E. Problems withradical corrective surgery after ascending aorta to right pulmonary artery shunt (Waterston's anastomosis) for cyanotic congenital heart disease. Br Heart J 1975; 37(11): 1105-12.

Kirklin JW, Blackstone EH, Pacifico AD, Brown RN, Bargeron LM Jr. Routine primary repair vs two-stage repair of tetralogy of Fallot. Circulation 1979; 60(2): 373-86.

Kirklin JW, Blackstone EH, Kirklin JK, Pacifico AD, Aramendi J, Bargeron LM Jr. Surgical results and protocols in the spectrum of tetralogy of Fallot. Ann Surg 1983; 198(3): 251-65.

Cole RB, Muster AJ, Fixler DE, Paul MH. Long-term results of aortopulmonary anastomosis for tetralogy of fallot: morbidity and mortality, 1946-1969. Circulation 1971; 43(2): 263-71.

Harris AM, Segel N, Bishop JM. Blalock-Taussig anastomosis for tetralogy of Fallot: a ten to fifteen year follow-up. Br Heart J 1964; 26: 266-7.

Neches WH, Naifeh JG, Park SC, Lenox CC, Zuberbuhler JR, Siewers RD, et al. Systemic-pulmonary artery anastomoses in infancy. J Thorac Cardiovasc Surg 1975; 70(5): 921-7.

Bernhard WF, Jones JE, Friedberg DZ, Litwin SB. Ascending aorta-right pulmonary artery shunt in infants and older patients with certain types of cyanotic congenital heart disease. Circulation 1971; 43(4): 580-4.

Laks H, Marco JD, Willman VL. The Blalock-Taussig shunt in the first six months of life. J Thorac Cardiovasc Surg 1975; 70(4): 687-91.

Wood WC, McCue CM, Lower RR. Blalock-Taussig shunts in the infant. Ann Thorac Surg. 1973; 16(5): 454-7.

Reitman MJ, Galioto FM Jr, el-Said GM, Cooley DA, Hallman GL, McNamara DG. Ascending aorta to right pulmonary artery anastomosis. Immediate results in 123 patients and one month to six year follow-up in 74 patients. Circulation 1974; 49(5): 952-7.

Somerville J, Yacoub M, Ross DN, Ross K. Aorta to right pulmonary artery anastomosis (Waterston's operation) for cyanotic heart disease. Circulation 1969; 39(5): 593-602.

Truccone NJ, Bowman FO Jr, Malm JR, Gersony WM. Systemic-pulmonary arterial shunts in the first year of life. Circulation 1974; 49(3): 508-11.

Chopra PS, Levy JM, Dacumos GC Jr, Berkoff HA, Loring LL, Kahn DR. The Blalock-Taussig operation: the procedure of choice in the hypoxic infant with tetralogy of Fallot. Ann Thorac Surg 1976; 22(3): 235-8.

Donahoo JS, Gardner TJ, Zahka K, Kidd BS. Systemic- Pulmonary shunts inneonates and infants using microporousexpanded polytetrafluoroethylene: immediate and lateresults. Ann Thorac Surg1980; 30(2): 146-50.

Kay PH, Capuani A, Franks R, Lincoln C. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts. Br Heart J 1983; 49(4): 359-63.

Lamberti JJ, Carlisle J, Waldman JD, Lodge FA, Kirkpatrick SE, George L, et al. Systemic-pulmonary shunts in infants and children. Early and late results. J Thorac CardiovascSurg 1984; 88(1): 76-81.

Woolf PK, Stephenson LW, Meijboom E, Bavinck JH, Gardner TJ, Donahoo JS, et al. A comparison of Blalock- Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age. Ann Thorac Surg 1984; 38(1): 26-30.

Wright J, Albrecht H, Beveridge J. Palliation in cyanotic congenital heart disease. Fifteen years' experience of various shunt procedures. Med J Aust 1986; 144(4): 178-9, 182.

Maghur HA, Ben-Musa AA, Salim ME, Abuzakhar SS. The modified Blalock-Taussig shunt: a 6-year experience from a developing country. Pediatr Cardiol 2002; 23(1): 49-52.

Fenchel G, Steil E, Seboldt H, Quintenz R, Apitz J, Hoffmeister HE. Early and late results of the modified Waterston shunt with PTFE grafts for palliation of complex congenital cyanotic heart disease in neonates. Thorac Cardiovasc Surg 1991; 39(5): 268-72.

Di Benedetto G, Tiraboschi R, Vanini V, Annecchino P, Aiazzi L, Caprioli C, et al. Systemic-pulmonary artery shunt using PTFE prosthesis (Gore-Tex). Early results and long-term follow-up on 105 consecutive cases. Thorac Cardiovasc Surg 1981; 29(3): 143-7.

Files
IssueVol 47, No 2 (2009) QRcode
SectionOriginal Article(s)
Keywords
Congenital heart disease cardiovascular surgery shunts

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Hashemzadeh K, Hashemzadeh S, Kakaei F. Outcome of Systemic-to-Pulmonary Shunts in Cyanotic Congenital Heart Disease- A 9-year Experience. Acta Med Iran. 1;47(2):109-114.